Wilson Sonsini Goodrich & Rosati advised Versant Ventures and NEA on the deal.Stablix Therapeutics announced a $63 million Series A financing. The funding round was led…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
